Clinical Trials

Pain, Postoperative, Pituitary Neoplasms

NCT04104529 2026-06-04

BCB RIV

EndocrineGenitourinaryHead & NeckNET

350 enrolled

Prostatic Neoplasms, Thyroid Neoplasms, Neuroendocrine Tumors

NCT04339036 2026-06-04

CapTemY90

70 enrolled

Neuroendocrine Tumors

NCT04954820 2026-06-04

ReLUTH

146 enrolled

Neuroendocrine Tumors, Disease Progression

NCT06607692 2026-06-04

LUPARPED

Phase 1/2 Recruiting

25 enrolled

CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT07612748 2026-06-03

Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms

483 enrolled

Rectal Neuroendocrine Tumors

NCT04042753 2026-06-02

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

Phase 2 Completed

10 enrolled

Pituitary Diseases, Pituitary Neoplasms

NCT07621146 2026-06-02

NET-COMPARE

Not yet recruiting

51 enrolled

CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Carcinoma, Medullary, Neuroendocrine Tumors

NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

20 enrolled

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT07068542 2026-06-01

TROPION

94 enrolled

Thyroid Carcinoma, Anaplastic

NCT07584447 2026-06-01

Clinical Utility of Preoperative Thyroid GuidePx® Testing

Not yet recruiting

85 enrolled

Phase NA Not yet recruiting

Thyroid Cancer, Papillary

NCT07618949 2026-06-01

Standardized Patient Education in Pituitary Surgery

102 enrolled

Pituitary Neoplasms

NCT00107289 2026-05-29

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Phase EARLY_PHASE1 Recruiting

200 enrolled

CNSEndocrine

Neuroblastoma, Pheochromocytoma

NCT07460232 2026-05-29

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

50 enrolled

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT03449108 2026-05-22

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

BreastEndocrineGynecologicHead & NeckSarcoma

30 enrolled

Bone Neoplasms, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Giant Cell Tumor of Bone, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms, Thyroid Carcinoma, Anaplastic

NCT05263050 2026-05-22

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

EndocrineGenitourinaryNET

111 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

200 enrolled

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

NCT06430021 2026-05-22

PRO-NEM1

297 enrolled

Neuroendocrine Tumors

NCT06959641 2026-05-22

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

33 enrolled

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT00461188 2026-05-20

Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA

10,000 enrolled

Pituitary Adenoma, Familial Isolated, Acromegaly, Gigantism

NCT04087902 2026-05-20

Long-Term Longitudinal QoL in Patients Undergoing EEA

Active not recruiting

400 enrolled

CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

NCT04759911 2026-05-20

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

30 enrolled

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT07376837 2026-05-19

PTC-RFA

30 enrolled

Phase NA Enrolling by invitation

Thyroid Cancer, Papillary

NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

1,600 enrolled

CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

NCT06881992 2026-05-18

Tumor HI

Phase 3 Recruiting

16 enrolled

EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT07532954 2026-05-18

The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support

40 enrolled

EndocrineGynecologic

Neuroendocrine Cervical Cancer

NCT07594262 2026-05-18

NET-TIME

60 enrolled

Pituitary Neoplasms

NCT06122610 2026-05-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1 Recruiting

10 enrolled

Phase 3 Not yet recruiting

Neuroendocrine Tumors

NCT07591493 2026-05-15

ADJUPANET

300 enrolled

Pancreatic Neuroendocrine Tumors (pNET)

NCT02750371 2026-05-14

ISOMAB

Phase NA Completed

17 enrolled

Pituitary Neoplasms

NCT05988918 2026-05-14

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

17 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Somatostatinoma, Carcinoma, Adenosquamous

NCT06735560 2026-05-13

ELEGANCE

60 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Carcinoma, Hepatocellular, Cholangiocarcinoma, Neuroendocrine Tumors

NCT07585032 2026-05-13

EUSRFAINSU

20 enrolled

Phase NA Active not recruiting

Insulinoma

NCT01704586 2026-05-12

CLERAD-PROBE

340 enrolled